Skip to main content
TipRanks
Go Ultimate75% OFF

Altamira Therapeutics (CYTOF) Ratios

600 Followers

Altamira Therapeutics Ratios

CYTOF's free cash flow for Q2 2023 was CHF-3.86M. For the 2023 fiscal year, CYTOF's free cash flow was increased by CHF0.00 and operating cash flow was CHF-3.86M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 23Dec 22Dec 21Dec 20Dec 19
Liquidity Ratios
Leverage Ratios
Profitability Margins
Efficiency Ratios
Cash Flow Ratios
Valuation Ratios
Tax and Other Ratios

Currency in CHF